- 94k views
Cardiac arrest and its management in emergency
In recent years, significant advances have been made in the treatment of rheumatoid arthritis (RA), a chronic autoimmune disease that primarily affects the joints. These advancements have revolutionized the management of RA, providing new hope and improved outcomes for patients. Biologic drugs have emerged as a game-changer in RA treatment. These medications specifically target molecules and pathways involved in the immune response, such as tumor necrosis factor (TNF), interleukin-6 (IL-6), and Janus kinase (JAK) enzymes. Biologics have shown remarkable efficacy in reducing inflammation, slowing disease progression, and improving overall joint function. The concept of personalized medicine has gained prominence in RA treatment. Genetic testing and biomarker analysis help identify specific characteristics and disease mechanisms in individual patients. This information enables physicians to tailor treatment strategies, selecting the most appropriate medications and dosages for each person, leading to better outcomes. In cases where joint damage is severe and non-responsive to medical therapy, surgical interventions have also seen advancements. Joint replacement surgeries, such as total hip or knee replacements, have become increasingly sophisticated and durable, relieving pain and restoring mobility for individuals with advanced RA.
About the Speaker
Dr.Vishant Sharma
Medical officer, Dept of Emergency, Civil Hospital District Shimla, Dept of Health and family welfare, Himachal Pradesh
Dr Vishant sharma completed his MBBS from rajiv gandhi university bangalore. Diploma in community mental health , nimhans bangalore . Dept of health and family welfare for himachal pradesh for 5 years. Masters in emergency medicine and trauma USA. Currently working in max super speciality hospital gurgaon Haryana.
Upcoming Case Discussions
Treatment of Renal Disease in ANCA Vasculitis
The treatment of renal disease in ANCA-associated vasculitis (AAV) typically involves a combination of immunosuppressive therapies to control inflammation and prevent further kidney damage. First-line treatment often includes high-dose corticosteroids and cyclophosphamide or rituximab, both of which help to induce remission by targeting the underlying immune system dysfunction. In cases of kidney failure or rapidly progressive glomerulonephritis, plasmapheresis may be used to remove circulating autoantibodies. Once remission is achieved, maintenance therapy with lower doses of immunosuppressants, such as azathioprine or mycophenolate mofetil, is used to prevent relapses and preserve kidney function.
Pulmonary Tuberculosis: Challenges in Diagnosis
Diagnosing pulmonary tuberculosis (TB) poses significant challenges, particularly in resource-limited settings. The disease often mimics other respiratory conditions, leading to delayed or missed diagnoses. Traditional diagnostic methods like sputum smear microscopy have limited sensitivity, especially in HIV co-infected or low-bacterial-load patients. Advanced techniques such as GeneXpert and culture tests, though more accurate, are often unavailable in remote areas. Children and immunocompromised patients present additional hurdles due to atypical symptoms and difficulty obtaining diagnostic samples. Non-specific imaging findings further complicate diagnosis. Addressing these challenges requires expanded access to molecular diagnostics, improved point-of-care tools, and greater healthcare awareness.
NIV in Acute Respiratory Failure
Dr Viny Kantroo is a Chest, Critical Care & Sleep medicine specialist based in Delhi, boasting over more than 15 years of professional experience. She is currently practising as a full time Senior consultant in Indraprastha Apollo Hospitals New Delhi and Visiting Consultant Apollo Hospitals Noida in the department of Respiratory, Critical Care and Sleep Medicine. She is recognised for her expertise in various aspects of Chest medicine, which includes EBUS (Convex probe, Radial), Bronchoscopic procedures, pleural effusion management, interstitial lung disease, Covid-19, lung cancer, pneumonia, and intensive care patient management. Dr Kantroo is renowned not only for her medical proficiency but also for her empathy and positive attitude towards patient care. Patients consulting with Dr Viny can be assured of receiving an accurate diagnosis and effective treatment, thanks to her commitment to prompt and comprehensive care.
AI in Genetics and Genomics
AI is revolutionizing genetics and genomics by enabling faster and more accurate analysis of complex genetic data. Machine learning algorithms can identify patterns in DNA sequences, helping to discover new genetic variants linked to diseases. Additionally, AI assists in predicting gene functions, personalizing medicine, and accelerating drug development. Its integration promises significant advancements in understanding genetic diseases and improving healthcare outcomes.
Management of Pediatric Type 1 Diabetes
Pediatric type 1 diabetes management focuses on maintaining glycemic control while supporting normal growth. Insulin therapy, via multiple daily injections or pumps, is essential, with doses adjusted based on blood glucose monitoring or continuous glucose monitoring (CGM). Nutrition plans emphasizing carbohydrate counting and balanced meals are crucial, alongside adjustments for physical activity to prevent glucose fluctuations. Education for families on recognizing hypo- and hyperglycemia symptoms and managing sick days is vital. Regular follow-ups with a pediatric endocrinologist help monitor HbA1c levels, growth, and complications. Psychosocial support is key for ensuring adherence and addressing emotional challenges.
Author Post
Impact
+
Talks
+
webinar
+
no.of registrations
One liner about speaker
Why is speaker relevant?
Dr.Vishant Sharma 's Talks on Assimilate
- 11th-December-2023, TIME : 06:00PM - 07:00PM
- 0
In recent years, significant advances have been made in the treatment of rheumatoid arthritis (RA), a chronic autoimmune disease that primarily affects the joints. These advancements have revolutionized the management of RA, providing new hope and improved outcomes for patients. Biologic drugs have emerged as a game-changer in RA treatment. These medications specifically target molecules and pathways involved in the immune response, such as tumor necrosis factor (TNF), interleukin-6 (IL-6), and Janus kinase (JAK) enzymes. Biologics have shown remarkable efficacy in reducing inflammation, slowing disease progression, and improving overall joint function. The concept of personalized medicine has gained prominence in RA treatment. Genetic testing and biomarker analysis help identify specific characteristics and disease mechanisms in individual patients. This information enables physicians to tailor treatment strategies, selecting the most appropriate medications and dosages for each person, leading to better outcomes. In cases where joint damage is severe and non-responsive to medical therapy, surgical interventions have also seen advancements. Joint replacement surgeries, such as total hip or knee replacements, have become increasingly sophisticated and durable, relieving pain and restoring mobility for individuals with advanced RA.
- 11th-December-2023, TIME : 06:00PM - 07:00PM
- 0
In recent years, significant advances have been made in the treatment of rheumatoid arthritis (RA), a chronic autoimmune disease that primarily affects the joints. These advancements have revolutionized the management of RA, providing new hope and improved outcomes for patients. Biologic drugs have emerged as a game-changer in RA treatment. These medications specifically target molecules and pathways involved in the immune response, such as tumor necrosis factor (TNF), interleukin-6 (IL-6), and Janus kinase (JAK) enzymes. Biologics have shown remarkable efficacy in reducing inflammation, slowing disease progression, and improving overall joint function. The concept of personalized medicine has gained prominence in RA treatment. Genetic testing and biomarker analysis help identify specific characteristics and disease mechanisms in individual patients. This information enables physicians to tailor treatment strategies, selecting the most appropriate medications and dosages for each person, leading to better outcomes. In cases where joint damage is severe and non-responsive to medical therapy, surgical interventions have also seen advancements. Joint replacement surgeries, such as total hip or knee replacements, have become increasingly sophisticated and durable, relieving pain and restoring mobility for individuals with advanced RA.
- 11th-December-2023, TIME : 06:00PM - 07:00PM
- 0
In recent years, significant advances have been made in the treatment of rheumatoid arthritis (RA), a chronic autoimmune disease that primarily affects the joints. These advancements have revolutionized the management of RA, providing new hope and improved outcomes for patients. Biologic drugs have emerged as a game-changer in RA treatment. These medications specifically target molecules and pathways involved in the immune response, such as tumor necrosis factor (TNF), interleukin-6 (IL-6), and Janus kinase (JAK) enzymes. Biologics have shown remarkable efficacy in reducing inflammation, slowing disease progression, and improving overall joint function. The concept of personalized medicine has gained prominence in RA treatment. Genetic testing and biomarker analysis help identify specific characteristics and disease mechanisms in individual patients. This information enables physicians to tailor treatment strategies, selecting the most appropriate medications and dosages for each person, leading to better outcomes. In cases where joint damage is severe and non-responsive to medical therapy, surgical interventions have also seen advancements. Joint replacement surgeries, such as total hip or knee replacements, have become increasingly sophisticated and durable, relieving pain and restoring mobility for individuals with advanced RA.